KERX Keryx Biopharmaceuticals, Inc. Company Research Saturday,

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Astria Therapeutics Awards Stock Options for New Hires Astria Therapeutics, Inc. (Nasdaq: ATXS), based in Boston, is making significant strides in the realm of biopharmaceuticals. The company focuses on developing transformative therapies targeted at allergic and immunologic diseases. Recently, it granted stock options that allow employees to purchase 58,650 shares of its...

Opportunity for Class Action in Constellation Brands Lawsuit If you are an investor who has experienced significant losses with Constellation Brands, Inc. (NYSE: STZ), you may have the opportunity to take a leading role in a class action lawsuit against the company. This lawsuit is a chance for affected shareholders to voice their grievances and seek restitution for their...

Bitcoin Soars Past $100,000 Amid Political Shifts Bitcoin has recently reached a remarkable milestone, crossing the $100,000 mark, with its price hitting $101,372.1. This surge is fueled by rising optimism regarding changes in U.S. cryptocurrency policies, especially with the upcoming presidential inauguration. Expectations of Crypto-Friendly Policies Fuel Bitcoin's Rise...

Research Insights on Low-Wage Americans and AI Recent research conducted highlights critical insights into the attitudes of low-wage Americans towards artificial intelligence, education, and their views on economic mobility. As technology continues to evolve, understanding these perspectives helps illuminate the challenges and opportunities faced by this demographic. The...

GSR IV Acquisition Corp. Announces Successful IPO Pricing GSR IV Acquisition Corp. (NASDAQ: GSRF) has recently announced an exciting milestone—the pricing of its initial public offering (IPO). With units set at a price of $10.00 each, this IPO aims to raise a total of $200 million, with plans to offer 20,000,000 units to potential investors. This anticipated move is...